A statin-dependent QTL for GATM expression is associated with statin-induced myopathy

The Human Genome Browser at UCSC

Kent, W. J., Sugnet, C. W., Furey, T. S., Roskin, K. M., Pringle, T. H., Zahler, A. M., & Haussler, A. D. (2002) · Genome Research · doi:10.1101/gr.229102 · Cited by 10,400 · see citing works

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins

(2005) · The Lancet · doi:10.1016/s0140-6736(05)67394-1 · Cited by 6,848 · see citing works

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807646 · Cited by 6,674 · see citing works

A Direct Approach to False Discovery Rates

Storey, J. D. (2002) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/1467-9868.00346 · Cited by 5,603 · see citing works

The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor

Brown, M. S., & Goldstein, J. L. (1997) · Cell · doi:10.1016/s0092-8674(00)80213-5 · Cited by 3,834 · see citing works

Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein

Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J. J., Gotto, A. M., Kastelein, J. J. P., Köenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2009) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000344393.60303.0a · Cited by 3,641 · see citing works

Biological, clinical and population relevance of 95 loci for blood lipids

Teslovich, T. M., Musunuru, K., Smith, A. V., Edmondson, A. C., Stylianou, I. M., Koseki, M., Pirruccello, J. P., Ripatti, S., Chasman, D. I., Willer, C. J., et al. (2010) · Nature · doi:10.1038/nature09270 · Cited by 3,487 · see citing works

ChromHMM: automating chromatin-state discovery and characterization

Ernst, J., & Kellis, M. (2012) · Nature Methods · doi:10.1038/nmeth.1906 · Cited by 2,489 · see citing works

<i>SLCO1B1</i> Variants and Statin-Induced Myopathy — A Genomewide Study

(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801936 · Cited by 2,043 · see citing works

Capturing Heterogeneity in Gene Expression Studies by Surrogate Variable Analysis

Leek, J. T., & Storey, J. D. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030161 · Cited by 1,930 · see citing works

GSEA-P : a desktop application for Gene Set Enrichment Analysis

Subramanian, A., Kuehn, H., Gould, J., Tamayo, P., & Mesirov, J. P. (2007) · Bioinformatics · doi:10.1093/bioinformatics/btm369 · Cited by 1,380 · see citing works

Genetic analysis of genome-wide variation in human gene expression

Morley, M. P., Molony, C. M., Weber, T. M., Devlin, J. L., Ewens, K. G., Spielman, R. S., & Cheung, V. G. (2004) · Nature · doi:10.1038/nature02797 · Cited by 1,207 · see citing works

Population genomics of human gene expression

Stranger, B. E., Nica, A. C., Forrest, M. S., Dimas, A. S., Bird, C., Beazley, C., Ingle, C., Dunning, M., Flicek, P., Koller, D., et al. (2007) · Nature Genetics · doi:10.1038/ng2142 · Cited by 1,132 · see citing works

Multiple loci associated with indices of renal function and chronic kidney disease

Köttgen, A., Glazer, N. L., Dehghan, A., Hwang, S., Katz, R., Li, M., Yang, Q., Gudnason, V. G., Launer, L. J., Harris, T. B., et al. (2009) · Nature Genetics · doi:10.1038/ng.377 · Cited by 648 · see citing works

Imputation-Based Analysis of Association Studies: Candidate Regions and Quantitative Traits

Servin, B., & Stephens, M. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030114 · Cited by 520 · see citing works

Bayesian statistical methods for genetic association studies

Stephens, M., & Balding, D. J. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2615 · Cited by 465 · see citing works

Pharmacogenetic Study of Statin Therapy and Cholesterol Reduction

Chasman, D. I. (2004) · JAMA · doi:10.1001/jama.291.23.2821 · Cited by 453 · see citing works

Statin Therapy and Risk of Developing Type 2 Diabetes: A Meta-Analysis

Rajpathak, S. N., Kumbhani, D. J., Crandall, J., Barzilai, N., Alderman, M., & Ridker, P. M. (2009) · Diabetes Care · doi:10.2337/dc09-0738 · Cited by 439 · see citing works

Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges

Wilke, R. A., Lin, D. W., Roden, D. M., Watkins, P. B., Flockhart, D. A., Zineh, I., Giacomini, K. M., & Krauss, R. M. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2423 · Cited by 394 · see citing works

Genetic interactions between polymorphisms that affect gene expression in yeast

Brem, R. B., Storey, J. D., Whittle, J., & Kruglyak, L. (2005) · Nature · doi:10.1038/nature03865 · Cited by 298 · see citing works

Genome-Wide Association of Lipid-Lowering Response to Statins in Combined Study Populations

Barber, M., Mangravite, L. M., Hyde, C. L., Chasman, D. I., Smith, J. D., McCarty, C. A., Li, X., Wilke, R. A., Rieder, M. J., Williams, P. T., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009763 · Cited by 230 · see citing works

Statin myopathy: A common dilemma not reflected in clinical trials

Fernandez, G., Spatz, E. S., Jablecki, C. K., & Phillips, P. S. (2011) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.78a.10073 · Cited by 216 · see citing works

Genetic Analysis of Human Traits In Vitro: Drug Response and Gene Expression in Lymphoblastoid Cell Lines

Choy, E., Yelensky, R., Bonakdar, S., Plenge, R. M., Saxena, R., Jager, P. L. D., Shaw, S. Y., Wolfish, C. S., Slavik, J. M., Cotsapas, C. J., et al. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000287 · Cited by 210 · see citing works

Identification, Replication, and Functional Fine-Mapping of Expression Quantitative Trait Loci in Primary Human Liver Tissue

Innocenti, F., Cooper, G. M., Stanaway, I. B., Gamazon, E. R., Smith, J. D., Mirkov, S., Ramı́rez, J., Liu, W., Lin, Y. S., Moloney, C., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002078 · Cited by 205 · see citing works

Phenotypic Predictors of Response to Simvastatin Therapy Among African-Americans and Caucasians: The Cholesterol and Pharmacogenetics (CAP) Study

Simon, J. A., Lin, F., Hulley, S. B., Blanche, P. J., Waters, D. D., Shiboski, S. C., Rotter, J. I., Nickerson, D. A., Yang, H., Saad, M. F., et al. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.09.134 · Cited by 189 · see citing works

Practical Issues in Imputation-Based Association Mapping

Guan, Y., & Stephens, M. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000279 · Cited by 171 · see citing works

The effects of EBV transformation on gene expression levels and methylation profiles

Çalışkan, M., Cusanovich, D. A., Ober, C., & Gilad, Y. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr041 · Cited by 134 · see citing works

Supervised normalization of microarrays

Mecham, B. H., Nelson, P. S., & Storey, J. D. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq118 · Cited by 130 · see citing works

Systems genetics analysis of gene-by-environment interactions in human cells

Romanoski, C. E., Lee, S., Kim, M. J., Ingram-Drake, L., Plaisier, C. L., Yordanova, R., Tilford, C., Guan, B., He, A., Gargalovic, P. S., et al. (2010) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2010.02.002 · Cited by 111 · see citing works

Impact of common genetic variation on response to simvastatin therapy among 18 705 participants in the Heart Protection Study

Hopewell, J. C., Parish, S., Offer, A. R., Link, E. K., Clarke, R., Lathrop, M. G., Armitage, J., Collins, R., & on behalf of the MRC/BHF Heart Protection Study Collaborative Group (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs344 · Cited by 107 · see citing works

Interactions between Glucocorticoid Treatment and Cis-Regulatory Polymorphisms Contribute to Cellular Response Phenotypes

Maranville, J., Luca, F., Richards, A. L., Wen, X., Witonsky, D., Baxter, S. S., Stephens, M., & Rienzo, A. D. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002162 · Cited by 101 · see citing works

l-arginine:glycine amidinotransferase deficiency protects from metabolic syndrome

Choe, C., Nabuurs, C. I. H. C., Stockebrand, M. C., Neu, A. D., Nunes, P. M., Morellini, F., Sauter, K., Schillemeit, S., Hermans‐Borgmeyer, I., Marescau, B., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds407 · Cited by 96 · see citing works

Global Analysis of the Impact of Environmental Perturbation on cis-Regulation of Gene Expression

Grundberg, E., Adoue, V., Kwan, T., Ge, B., Duan, Q., Lam, K. C. L., Koka, V., Kindmark, A., Weiss, S. T., Tantisira, K. G., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1001279 · Cited by 79 · see citing works

Combined Influence of LDLR and HMGCR Sequence Variation on Lipid-Lowering Response to Simvastatin

Mangravite, L. M., Medina, M. W., Cui, J., Pressman, S., Smith, J. D., Rieder, M. J., Guo, X., Nickerson, D. A., Rotter, J. I., & Krauss, R. M. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.203273 · Cited by 77 · see citing works

Coordinately Regulated Alternative Splicing of Genes Involved in Cholesterol Biosynthesis and Uptake

Medina, M. W., Gao, F., Naidoo, D., Rudel, L. L., Temel, R. E., McDaniel, A. L., Marshall, S., & Krauss, R. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019420 · Cited by 68 · see citing works

l-arginine:glycine amidinotransferase (AGAT) deficiency: Clinical presentation and response to treatment in two patients with a novel mutation

Edvardson, S., Korman, S. H., Livne, A., Shaag, A., Saada, A., Nalbandian, R., Allouche‐Arnon, H., Gomori, J. M., & Katz‐Brull, R. (2010) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2010.06.021 · Cited by 55 · see citing works

Genetic variation in radiation-induced cell death

Smirnov, D. A., Brady, L., Halasa, K., Morley, M., Solomon, S., & Cheung, V. G. (2012) · Genome Research · doi:10.1101/gr.122044.111 · Cited by 46 · see citing works

Epstein-Barr virus transformation of cryopreserved lymphocytes: prolonged experience with technique.

Pressman, S., & Rotter, J. (1991) · PubMed · Cited by 46 · see citing works

Replication of LDL GWAs hits in PROSPER/PHASE as validation for future (pharmaco)genetic analyses

the PROSPER study group, Trompet, S., de Craen, A. J. M., Postmus, I., Ford, I., Sattar, N. A., CASLAKE, M. J., Stott, D. J., Buckley, B. M., Sacks, F. M., et al. (2011) · BMC Medical Genetics · doi:10.1186/1471-2350-12-131 · Cited by 39 · see citing works

Use of an Electronic Medical Record to Characterize Cases of Intermediate Statin‐Induced Muscle Toxicity

Mareedu, R. K., Modhia, F., Kanin, E. I., Linneman, J. G., Kitchner, T., McCarty, C. A., Krauss, R. M., & Wilke, R. A. (2009) · Preventive Cardiology · doi:10.1111/j.1751-7141.2009.00028.x · Cited by 20 · see citing works

Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management

Stroes, E. S., Thompson, P. D., Corsini, A., Vladutiu, G. D., Raal, F. J., Ray, K. K., Roden, M., Stein, E., Tokgözoğlu, L., Nordestgaard, B. G., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv043 · Cited by 1,443 · see citing works

The role of regulatory variation in complex traits and disease

Albert, F. W., & Kruglyak, L. (2015) · Nature Reviews Genetics · doi:10.1038/nrg3891 · Cited by 1,047 · see citing works

Statin Toxicity

Ward, N. C., Watts, G. F., & Eckel, R. H. (2019) · Circulation Research · doi:10.1161/circresaha.118.312782 · Cited by 772 · see citing works

The pharmacology of statins

Sirtori, C. R. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2014.03.002 · Cited by 705 · see citing works

Systems genetics approaches to understand complex traits

Civelek, M., & Lusis, A. J. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3575 · Cited by 621 · see citing works

A Multivariate Genome-Wide Association Analysis of 10 LDL Subfractions, and Their Response to Statin Treatment, in 1868 Caucasians

Shim, H., Chasman, D. I., Smith, J. D., Mora, S., Ridker, P. M., Nickerson, D. A., Krauss, R. M., & Stephens, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120758 · Cited by 552 · see citing works

Transcription factors operate across disease loci, with EBNA2 implicated in autoimmunity

Harley, J. B., Chen, X., Pujato, M. A., Miller, D., Maddox, A., Forney, C. R., Magnusen, A. F., Lynch, A., Chetal, K., Yukawa, M., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0102-3 · Cited by 409 · see citing works

Where Are the Disease-Associated eQTLs?

Umans, B. D., Battle, A., & Gilad, Y. (2021) · Trends in Genetics · doi:10.1016/j.tig.2020.08.009 · Cited by 296 · see citing works

Effects of statins on mitochondrial pathways

Mollazadeh, H., Tavana, E., Fanni, G., Bo, S., Banach, M., Pirro, M., von Haehling, S., Jamialahmadi, T., & Sahebkar, A. (2021) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12654 · Cited by 259 · see citing works

Diagnosis, Prevention, and Management of Statin Adverse Effects and Intolerance: Canadian Consensus Working Group Update (2016)

Mancini, G. B. J., Baker, S. K., Bergeron, J., FITCHETT, D. H., Frohlich, J. J., Genest, J. J., Gupta, M., Hegele, R. A., Ng, D. S., Pearson, G. J., et al. (2016) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2016.01.003 · Cited by 253 · see citing works

Statin-Induced Myopathy Is Associated with Mitochondrial Complex III Inhibition

Schirris, T. J. J., Renkema, G. H., Ritschel, T., Voermans, N. C., Bilos, A., van Engelen, B. G. M., Brandt, U., Koopman, W. J. H., Beyrath, J., Rodenburg, R. J., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.08.002 · Cited by 227 · see citing works

Predicting genome-wide DNA methylation using methylation marks, genomic position, and DNA regulatory elements

Zhang, W., Spector, T. D., Deloukas, P., Bell, J. T., & Engelhardt, B. E. (2015) · Genome biology · doi:10.1186/s13059-015-0581-9 · Cited by 198 · see citing works

Statin-Related Myotoxicity: A Comprehensive Review of Pharmacokinetic, Pharmacogenomic and Muscle Components

Turner, R. M., & Pirmohamed, M. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm9010022 · Cited by 201 · see citing works

Side effects of statins: from pathophysiology and epidemiology to diagnostic and therapeutic implications

Ruscica, M., Ferri, N., Banach, M., Sirtori, C. R., & Corsini, A. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac020 · Cited by 209 · see citing works

Statin-Associated Myopathy: Emphasis on Mechanisms and Targeted Therapy

Vinci, P., Panizon, E., Tosoni, L. M., Cerrato, C., Pellicori, F., Mearelli, F., Biasinutto, C., Fiotti, N., Girolamo, F. G. D., & Biolo, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111687 · Cited by 180 · see citing works

Diagnosis, prevention, and management of statin adverse effects and intolerance: Canadian Working Group Consensus update

Mancini, G. B. J., Tashakkor, A. Y., Baker, S., Bergeron, J., Fitchett, D., Frohlich, J., Genest, J., Gupta, M., Hegele, R. A., Ng, D. S., et al. (2013) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2013.09.023 · Cited by 173 · see citing works

In Vitro Human Cell Line Models to Predict Clinical Response to Anticancer Drugs

Niu, N., & Wang, L. (2015) · Pharmacogenomics · doi:10.2217/pgs.14.170 · Cited by 175 · see citing works

Personalized Pharmacogenomics: Predicting Efficacy and Adverse Drug Reactions

Pirmohamed, M. (2014) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-090413-025419 · Cited by 169 · see citing works

Gene-centric Meta-analysis in 87,736 Individuals of European Ancestry Identifies Multiple Blood-Pressure-Related Loci

Tragante, V., Barnes, M. R., Ganesh, S. K., Lanktree, M. B., Guo, W., Franceschini, N., Smith, E. N., Johnson, T., Holmes, M. V., Padmanabhan, S., et al. (2014) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.12.016 · Cited by 168 · see citing works

Lipin-1 regulates autophagy clearance and intersects with statin drug effects in skeletal muscle

Zhang, P., Verity, M. A., & Reue, K. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.05.003 · Cited by 166 · see citing works

Pharmacogenetics to guide cardiovascular drug therapy

Duarte, J. D., & Cavallari, L. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00549-w · Cited by 119 · see citing works

Heritability of variation in glycaemic response to metformin: a genome-wide complex trait analysis

Zhou, K., Donnelly, L. A., Yang, J., Li, M., Deshmukh, H., Zuydam, N. V., Ahlqvist, E., Spencer, C. C. A., Groop, L., Morris, A. D., et al. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70050-6 · Cited by 125 · see citing works

High-throughput allele-specific expression across 250 environmental conditionsPreprint

Moyerbrailean, G. A., Richards, A. L., Kurtz, D. A., Kalita, C. A., Davis, G. O., Harvey, C. T., Alazizi, A., Watza, D., Sorokin, Y., Hauff, N., et al. (2016) · Genome Research · doi:10.1101/gr.209759.116 · Cited by 115 · see citing works

Redefining the IBDs using genome-scale molecular phenotyping

Furey, T. S., Sethupathy, P., & Sheikh, S. Z. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0118-x · Cited by 115 · see citing works

Mechanisms and assessment of statin‐related muscular adverse effects

Moßhammer, D., Schaeffeler, E., Schwab, M. G., & Mörike, K. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12360 · Cited by 110 · see citing works

Four Susceptibility Loci for Gallstone Disease Identified in a Meta-analysis of Genome-Wide Association Studies

Joshi, A. D., Andersson, C., Buch, S., Stender, S., Noordam, R., Weng, L.-C. C., Weeke, P., Auer, P. L., Boehm, B. O., Chen, C., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.04.007 · Cited by 105 · see citing works

Dermatomyositis, polymyositis and immune-mediated necrotising myopathies

Luo, Y., & Mastaglia, F. L. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.05.034 · Cited by 104 · see citing works

Functional Genomics of Host–Microbiome Interactions in Humans

Luca, F., Kupfer, S. S., Knights, D., Khoruts, A., & Blekhman, R. (2017) · Trends in Genetics · doi:10.1016/j.tig.2017.10.001 · Cited by 99 · see citing works

Prediction of human population responses to toxic compounds by a collaborative competition

Eduati, F., Mangravite, L. M., Wang, T., Tang, H., Bare, J. C., Huang, R., Norman, T., Kellen, M., Menden, M. P., Yang, J., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3299 · Cited by 95 · see citing works

Systems biology approaches to adverse drug effects: the example of cardio-oncology

Brown, S.-A. N., Sandhu, N. P., & Herrmann, J. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.168 · Cited by 95 · see citing works

Statins, Muscle Disease and Mitochondria

Ramachandran, R., & Wierzbicki, A. S. (2017) · Journal of Clinical Medicine · doi:10.3390/jcm6080075 · Cited by 91 · see citing works

The AKT/mTOR signaling pathway plays a key role in statin-induced myotoxicity

Bonifacio, A., Sanvee, G. M., Bouitbir, J., & Krähenbühl, S. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.04.010 · Cited by 93 · see citing works

Joint analysis of expression levels and histological images identifies genes associated with tissue morphology

Ash, J. T., Darnell, G., Munro, D. B., & Engelhardt, B. E. (2021) · Nature Communications · doi:10.1038/s41467-021-21727-x · Cited by 86 · see citing works

Prediction of Human Population Responses to Toxic Compounds by a Collaborative Competition

Bynagari, N. B. (2017) · Asian Journal of Humanity Art and Literature · doi:10.18034/ajhal.v4i2.577 · Cited by 91 · see citing works

Beyond sports: Efficacy and safety of creatine supplementation in pathological or paraphysiological conditions of brain and muscle

Balestrino, M., & Adriano, E. (2019) · Medicinal Research Reviews · doi:10.1002/med.21590 · Cited by 90 · see citing works

Pharmacogenomics of statins: understanding susceptibility to adverse effects

Kitzmiller, J., Mikulik, E., Dauki, A. M., Mukherjee, C., & Luzum, J. A. (2016) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s86013 · Cited by 92 · see citing works

Muscle- and skeletal-related side-effects of statins: tip of the iceberg?

Auer, J., Sinzinger, H. F., Franklin, B., & Berent, R. (2014) · European Journal of Preventive Cardiology · doi:10.1177/2047487314550804 · Cited by 85 · see citing works

Treatment Options for Statin-Associated Muscle Symptoms

Laufs, U., Scharnagl, H., Halle, M., Windler, E., Endres, M., & März, W. (2015) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2015.0748 · Cited by 83 · see citing works

Genetic factors affecting statin concentrations and subsequent myopathy: a HuGENet systematic review

Canestaro, W. J., Austin, M. A., & Thummel, K. E. (2014) · Genetics in Medicine · doi:10.1038/gim.2014.41 · Cited by 81 · see citing works

Atherosclerosis and Coronary Artery Disease

Zaromitidou, M., Siasos, G., Παπαγεωργίου, Ν., Oikonomou, E. K., & Tousoulis, D. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803312-8.00002-1 · Cited by 80 · see citing works

A comprehensive review and meta-analysis of risk factors for statin-induced myopathy

Nguyen, K. A., Li, L., Lu, D., Yazdanparast, A., Wang, L., Kreutz, R. P., Whipple, E. C., & Schleyer, T. (2018) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-018-2482-9 · Cited by 77 · see citing works

The virtuous cycle of human genetics and mouse models in drug discovery

Nadeau, J. H., & Auwerx, J. H. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-018-0009-9 · Cited by 71 · see citing works

Pharmacogenetics of Statin-Induced Myotoxicity

Kee, P. S., Chin, P. K. L., Kennedy, M. A., & Maggo, S. D. S. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.575678 · Cited by 72 · see citing works

Detecting differential growth of microbial populations with Gaussian process regressionPreprint

Tonner, P. D., Darnell, C. L., Engelhardt, B. E., & Schmid, A. (2016) · Genome Research · doi:10.1101/gr.210286.116 · Cited by 72 · see citing works

Role of genetics in the prediction of statin-associated muscle symptoms and optimization of statin use and adherence

Brunham, L. R., Baker, S. K., Mammen, A. L., Mancini, G. B. J., & Rosenson, R. S. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy119 · Cited by 71 · see citing works

Functional dynamic genetic effects on gene regulation are specific to particular cell types and environmental conditions

Findley, A. S., Monziani, A., Richards, A. L., Rhodes, K., Ward, M. C., Kalita, C. A., Alazizi, A., Pazokitoroudi, A., Sankararaman, S., Wen, X., et al. (2021) · eLife · doi:10.7554/elife.67077 · Cited by 66 · see citing works

Fine-mapping cis-regulatory variants in diverse human populations

Tehranchi, A. K., Hie, B., Dacre, M., Kaplow, I. M., Pettie, K. P., Combs, P. A., & Fraser, H. B. (2019) · eLife · doi:10.7554/elife.39595 · Cited by 65 · see citing works

Muscle Toxicity of Drugs: When Drugs Turn Physiology into Pathophysiology

Janssen, L., Allard, N. A. E., Saris, C. G. J., Keijer, J., Hopman, M. T. E., & Timmers, S. (2019) · Physiological Reviews · doi:10.1152/physrev.00002.2019 · Cited by 67 · see citing works

Statins and skeletal muscles toxicity: From clinical trials to everyday practice

Norata, G. D., Tibolla, G., & Catapano, A. L. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2014.04.012 · Cited by 64 · see citing works

Genotype × environment interactions in gene regulation and complex traits

Boye, C., Nirmalan, S., Ranjbaran, A., & Luca, F. (2024) · Nature Genetics · doi:10.1038/s41588-024-01776-w · Cited by 65 · see citing works

Cardiovascular Pharmacogenomics: Expectations and Practical Benefits

Turner, R. M., & Pirmohamed, M. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.234 · Cited by 63 · see citing works

HNRNPA1 regulates HMGCR alternative splicing and modulates cellular cholesterol metabolism

Yu, C.-Y., Theusch, E., Lo, K., Mangravite, L. M., Naidoo, D., Kutilova, M., & Medina, M. W. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt422 · Cited by 62 · see citing works

Genomewide Association Study of Statin‐Induced Myopathy in Patients Recruited Using the UK Clinical Practice Research Datalink

Carr, D. F., Francis, B., Jorgensen, A., Zhang, E., Chinoy, H., Heckbert, S. R., Bis, J. C., Brody, J. A., Floyd, J. S., Psaty, B. M., et al. (2019) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1557 · Cited by 59 · see citing works

Overcoming Challenges With Statin Therapy

Spence, J. D., & Dresser, G. K. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002497 · Cited by 56 · see citing works

Pharmacogenomics of statin-related myopathy: Meta-analysis of rare variants from whole-exome sequencing

Floyd, J. S., Bloch, K. M., Brody, J. A., Maroteau, C., Siddiqui, M. K., Gregory, R., Carr, D. F., Molokhia, M., Liu, X., Bis, J. C., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0218115 · Cited by 52 · see citing works

Advances in statin adverse reactions and the potential mechanisms: A systematic review

Zeng, W., Deng, H., Luo, Y., Zhong, S., Huang, M., & Tomlinson, B. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.12.020 · Cited by 53 · see citing works

Identification of 22 novel loci associated with urinary biomarkers of albumin, sodium, and potassium excretion

Zanetti, D., Rao, A. S., Gustafsson, S., Assimes, T. L., Montgomery, S. B., & Ingelsson, E. (2019) · Kidney International · doi:10.1016/j.kint.2018.12.017 · Cited by 51 · see citing works

Expert opinion: the therapeutic challenges faced by statin intolerance

Patel, J., Martin, S. S., & Banach, M. (2016) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2016.1197202 · Cited by 50 · see citing works

Bayesian group factor analysis with structured sparsity.

Zhao, S., Gao, C., Mukherjee, S., & Engelhardt, B. E. (2016) · PubMed · doi:10.5555/2946645.3053478 · Cited by 48 · see citing works

Statin myalgia is not associated with reduced muscle strength, mass or protein turnover in older male volunteers, but is allied with a slowing of time to peak power output, insulin resistance and differential muscle mRNA expression

Mallinson, J. E., Marimuthu, K., Murton, A. J., Selby, A., Smith, K., Constantin‐Teodosiu, D., Rennie, M. J., & Greenhaff, P. L. (2015) · The Journal of Physiology · doi:10.1113/jphysiol.2014.285577 · Cited by 47 · see citing works

Patients experiencing statin-induced myalgia exhibit a unique program of skeletal muscle gene expression following statin re-challenge

Elam, M. B., Majumdar, G., Mozhui, K., Gerling, I., VERA, S. R., Fish-Trotter, H. L., Williams, R. W., Childress, R. D., & Raghow, R. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181308 · Cited by 50 · see citing works

A method to identify and validate mitochondrial modulators using mammalian cells and the worm C. elegans

Andreux, P. A., Mouchiroud, L., Wang, X., Jovaisaite, V., Mottis, A., Bichet, S., Moullan, N., Houtkooper, R. H., & Auwerx, J. H. (2014) · Scientific Reports · doi:10.1038/srep05285 · Cited by 44 · see citing works

En route to precision medicine through the integration of biological sex into pharmacogenomics

Gaignebet, L., & Kararigas, G. (2017) · Clinical Science · doi:10.1042/cs20160379 · Cited by 44 · see citing works

Environmental influences on RNA processing: Biochemical, molecular and genetic regulators of cellular response

Pai, A. A., & Luca, F. (2018) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1503 · Cited by 47 · see citing works

Edematous severe acute malnutrition is characterized by hypomethylation of DNA

Schulze, K., Swaminathan, S., Howell, S., Jajoo, A., Lie, N. C., Brown, O., Sadat, R., Hall, N. J., Zhao, L., Marshall, K., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13433-6 · Cited by 44 · see citing works

GATM Polymorphism Associated with the Risk for Statin-Induced Myopathy Does Not Replicate in Case-Control Analysis of 715 Dyslipidemic Individuals

Luzum, J. A., Kitzmiller, J. P., Isackson, P. J., Ma, C., Medina, M. W., Dauki, A. M., Mikulik, E., Ochs‐Balcom, H. M., & Vladutiu, G. D. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.03.003 · Cited by 43 · see citing works

Statin-Induced Myopathy: Translational Studies from Preclinical to Clinical Evidence

Camerino, G. M., Tarantino, N., Canfora, I., Bellis, M. D., Musumeci, O., & Pierno, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042070 · Cited by 46 · see citing works

Local Adaptation of Sun-Exposure-Dependent Gene Expression Regulation in Human Skin

Kita, R., & Fraser, H. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1006382 · Cited by 22 · see citing works

Genetic and immunologic susceptibility to statin-related myopathy

Patel, J., Superko, H. R., Martin, S. S., Blumenthal, R. S., & Christopher‐Stine, L. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.03.025 · Cited by 38 · see citing works

Opportunities and Challenges in Cardiovascular Pharmacogenomics

Roden, D. M., Driest, S. L. V., Wells, Q. S., Mosley, J. D., Denny, J. C., & Peterson, J. F. (2018) · Circulation Research · doi:10.1161/circresaha.117.310965 · Cited by 38 · see citing works

Genetic Influences on Disease Subtypes

Dahl, A. W., & Zaitlen, N. (2020) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-120319-095026 · Cited by 36 · see citing works

Statin intolerance

Laufs, U., Scharnagl, H., & März, W. (2015) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000236 · Cited by 37 · see citing works

Adiposity-Dependent Regulatory Effects on Multi-tissue Transcriptomes

Glastonbury, C. A., Viñuela, A., Buil, A., Halldorsson, G. H., Þorleifsson, G., Helgason, H., Þorsteinsdóttir, U., Stefánsson, K., Dermitzakis, E. T., Spector, T. D., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.07.001 · Cited by 35 · see citing works

GATM gene variants and statin myopathy risk

Carr, D. F., Alfirevic, A., Johnson, R., Chinoy, H., van Staa, T., & Pirmohamed, M. (2014) · Nature · doi:10.1038/nature13628 · Cited by 35 · see citing works

Pharmacogenetics of Lipid-Lowering Agents: Precision or Indecision Medicine?

Alfonsi, J., Hegele, R. A., & Gryn, S. E. (2016) · Current Atherosclerosis Reports · doi:10.1007/s11883-016-0573-6 · Cited by 35 · see citing works

Statistical tests for detecting variance effects in quantitative trait studies

Dumitrascu, B., Darnell, G., Ayroles, J. F., & Engelhardt, B. E. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty565 · Cited by 35 · see citing works

Prediction of LDL cholesterol response to statin using transcriptomic and genetic variation

Kim, K., Bolotin, E., Theusch, E., Huang, H., Medina, M. W., & Krauss, R. M. (2014) · Genome biology · doi:10.1186/s13059-014-0460-9 · Cited by 32 · see citing works

Genetic and Clinical Factors Are Associated With Statin‐Related Myotoxicity of Moderate Severity: A Case–Control Study

Bakar, N. S., Neely, D., Avery, P. J., Brown, C., Daly, A. K., & Kamali, F. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.887 · Cited by 32 · see citing works

RYR1 and CACNA1S genetic variants identified with statin-associated muscle symptoms

Isackson, P. J., Wang, J., Zia, M., Spurgeon, P., Levesque, A., Bard, J., James, S. R., Nowak, N. J., Lee, T. K., & Vladutiu, G. D. (2018) · Pharmacogenomics · doi:10.2217/pgs-2018-0106 · Cited by 32 · see citing works

Reference intervals of plasma homoarginine from the German Gutenberg Health Study

Atzler, D., Appelbaum, S., Cordts, K., Ojeda, F., Wild, P. S., Münzel, T. F., Blankenberg, S., Böger, R. H., Blettner, M., Beutel, M. E., et al. (2015) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2015-0785 · Cited by 32 · see citing works

The Effects of Statin Medications on Aerobic Exercise Capacity and Training Adaptations

Murlasits, Z., & Radak, Z. O. (2014) · Sports Medicine · doi:10.1007/s40279-014-0224-4 · Cited by 32 · see citing works

Effects of SLCO1B1 and GATM gene variants on rosuvastatin-induced myopathy are unrelated to high plasma exposure of rosuvastatin and its metabolites

Bai, X., Zhang, B., Wang, P., Wang, G., Li, J., Wen, D., Long, X.-Z., Sun, H., Liu, Y., Huang, M., et al. (2018) · Acta Pharmacologica Sinica · doi:10.1038/s41401-018-0013-y · Cited by 31 · see citing works

Cardiovascular pharmacogenomics: current status and future directions

Roden, D. M. (2015) · Journal of Human Genetics · doi:10.1038/jhg.2015.78 · Cited by 31 · see citing works

The Expressed Genome in Cardiovascular Diseases and Stroke: Refinement, Diagnosis, and Prediction: A Scientific Statement From the American Heart Association

Musunuru, K., Ingelsson, E., Fornage, M., Liu, P. X., Murphy, A. M., Newby, L. K., Newton‐Cheh, C., Perez, M. V., Voora, D., & Woo, D. (2017) · Circulation Cardiovascular Genetics · doi:10.1161/hcg.0000000000000037 · Cited by 30 · see citing works

Transcriptomic variation of pharmacogenes in multiple human tissues and lymphoblastoid cell lines

Chhibber, A., French, C. E., Yee, S. W., Gamazon, E. R., Theusch, E., Qin, X., Webb, A., Papp, A. C., Wang, A., Simmons, C. Q., et al. (2016) · The Pharmacogenomics Journal · doi:10.1038/tpj.2015.93 · Cited by 29 · see citing works

GATM locus does not replicate in rhabdomyolysis study

Floyd, J. S., Bis, J. C., Brody, J. A., Heckbert, S. R., Rice, K. M., & Psaty, B. M. (2014) · Nature · doi:10.1038/nature13629 · Cited by 29 · see citing works

Analysis of transcriptional changes in the immune system associated with pubertal development in a longitudinal cohort of children with asthma

Resztak, J., Choe, J., Nirmalan, S., Wei, J., Bruinsma, J., Houpt, R., Alazizi, A., Mair-Meijers, H. E., Wen, X., Slatcher, R. B., et al. (2023) · Nature Communications · doi:10.1038/s41467-022-35742-z · Cited by 31 · see citing works

Changes in DNA methylation and imprinting disorders in E9.5 mouse fetuses and placentas derived from vitrified eight‐cell embryos

Ma, Y., Ma, Y., Wen, L., Lei, H., Chen, S., & Wang, X. (2019) · Molecular Reproduction and Development · doi:10.1002/mrd.23118 · Cited by 27 · see citing works

The causes of drug-induced muscle toxicity

Jones, J. D. G., Kirsch, H. L., Wortmann, R. L., & Pillinger, M. H. (2014) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000108 · Cited by 27 · see citing works

Incorporation of Biological Knowledge Into the Study of Gene-Environment Interactions

Ritchie, M. D., Davis, J. R., Aschard, H., Battle, A. J., Conti, D. V., Du, M., Eskin, E., Fallin, M. D., Hsu, L., Kraft, P., et al. (2017) · American Journal of Epidemiology · doi:10.1093/aje/kwx229 · Cited by 27 · see citing works

High-dose atorvastatin therapy progressively decreases skeletal muscle mitochondrial respiratory capacity in humans

RYAN, T. E., Torres, M. J., Lin, C., Clark, A. H., Brophy, P. M., Smith, C. A. S., Smith, C. D., Morris, E. M., Thyfault, J. P., & Neufer, P. D. (2024) · JCI Insight · doi:10.1172/jci.insight.174125 · Cited by 26 · see citing works

Genetic variants modulate gene expression statin response in human lymphoblastoid cell lines

Theusch, E., Chen, Y. I., Rotter, J. I., Krauss, R. M., & Medina, M. W. (2020) · BMC Genomics · doi:10.1186/s12864-020-06966-4 · Cited by 23 · see citing works

Pharmacogenomics: novel loci identification via integrating gene differential analysis and eQTL analysis

Qiu, W., Rogers, A. J., Damask, A., Raby, B. A., Klanderman, B. J., Duan, Q., Tyagi, S., Niu, S., Anderson, C. D., Cahir-McFarland, E. D., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu191 · Cited by 26 · see citing works

A possible role for HLA-DRB1*04:06 in statin-related myopathy in Japanese patients

Sai, K., Kajinami, K., Akao, H., Iwadare, M., Sato-Ishida, R., Kawai, Y., Takeda, K., Tanimoto, T., Yamano, T., Akasaka, T., et al. (2016) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2016.09.002 · Cited by 26 · see citing works

The Effect of Freeze-Thaw Cycles on Gene Expression Levels in Lymphoblastoid Cell Lines

Çalışkan, M., Pritchard, J. K., Ober, C., & Gilad, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107166 · Cited by 24 · see citing works

Personalised medicine in hypercholesterolaemia: the role of pharmacogenetics in statin therapy

Ahangari, N., Doosti, M., Ghayour‐Mobarhan, M., Sahebkar, A., Ferns, G. A., & Pasdar, A. (2020) · Annals of Medicine · doi:10.1080/07853890.2020.1800074 · Cited by 24 · see citing works

Pharmacogenomics, Lipid Disorders, and Treatment Options

Gryn, S. E., & Hegele, R. A. (2014) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2014.82 · Cited by 23 · see citing works

Statins block mammalian target of rapamycin pathway: a possible novel therapeutic strategy for inflammatory, malignant and neurodegenerative diseases

Lashgari, N., Roudsari, N. M., Zadeh, S. S. T., Momtaz, S., Abbasifard, M., Reiner, Ž., Abdolghaffari, A. H., & Sahebkar, A. (2022) · Inflammopharmacology · doi:10.1007/s10787-022-01077-w · Cited by 23 · see citing works

A polymorphism in HLA-G modifies statin benefit in asthma

Naidoo, D., Wu, A. C., Brilliant, M. H., Denny, J. C., Ingram, C., Kitchner, T., Linneman, J. G., McGeachie, M. J., Roden, D. M., Shaffer, C. M., et al. (2014) · The Pharmacogenomics Journal · doi:10.1038/tpj.2014.55 · Cited by 23 · see citing works

Is personalized medicine a dream or a reality?

Morse, B. L., & Kim, R. B. (2014) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2014.950407 · Cited by 23 · see citing works

GATM gene variants and statin myopathy risk

Carr, D. F., Alfirevic, A., Johnson, R., Chinoy, H., van Staa, T., & Pirmohamed, M. (2014) · Nature · doi:10.1038/nature13628 · Cited by 35 · see citing works

GATM gene involved in statin-induced myopathy

(2013) · Reactions Weekly · doi:10.1007/s40278-013-6064-4

Mangravite et al. reply

Mangravite, L. M., Engelhardt, B. E., Stephens, M., & Krauss, R. M. (2014) · Nature · doi:10.1038/nature13630 · Cited by 4 · see citing works

Muscle phenotype of AGAT- and GAMT-deficient mice after simvastatin exposure

Sasani, A., Hornig, S., Grzybowski, R., Cordts, K., Hanff, E., Tsikas, D., Böger, R. H., Gerloff, C. P., Isbrandt, D., Neu, A. D., et al. (2019) · Amino Acids · doi:10.1007/s00726-019-02812-4 · Cited by 12 · see citing works

Does Reduced Creatine Synthesis Protect against Statin Myopathy?

Ballard, K. D., & Thompson, P. D. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.11.012 · Cited by 14 · see citing works